News

Non-Invasive Diagnostic Test for IPF Shown Pulmonologists at CHEST 2016

Veracyte has announced the launch of its non-invasive test to improve the diagnosis of interstitial lung diseases, including  idiopathic pulmonary fibrosis (IPF). The soon-to-be commercially available test, Envisia Genomic Classifier, is reported to offer a faster and more accurate diagnosis than is currently available without the need for a lung biopsy. Data…

Phase 3 Data from INPULSIS Trials Confirm Efficacy of Ofev as IPF Treatment

Results from two Phase 3 studies, known as the INPULSIS trials, further confirmed the efficacy of Ofev (nintedanib) to treat idiopathic pulmonary fibrosis (IPF) regardless of disease severity. The results, from post-hoc pooled analyses of the trials, were recently presented at the CHEST 2016 Annual Meeting, running in Los Angeles through Wednesday, Oct. 26.

Mindfulness Program Designed Specifically to Empower IPF Patients

‘Exhale, Mindfully Manage Your IPF’ is a new initiative co-sponsored by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the Pulmonary Fibrosis Foundation, and the international biotechnology firm Genentech. The program’s aim is to help people living with idiopathic pulmonary fibrosis (IPF), and encourage…

NIH Awards $5.2M to Team Working on Lung Regeneration Therapies

The National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH) awarded a seven-year grant worth $5.2 million to a team of researchers looking into the cellular and molecular mechanisms that promote lung regeneration, and aiming to develop therapies for children with hereditary lung diseases and adults with pulmonary fibrosis…

PF Patient in Need of New Lungs Shares Her Story for World Organ Donation Day

Today, Oct. 17, is the 11th annual World Day for Organ Donation and Transplantation. While medical advances have resulted in increasing numbers of transplants performed each year, the availability of donor organs is still not enough to fulfill the urgent needs of all those awaiting a transplant. One reason for the limited availability is that…

Rare Group of T-Cells Trigger and Sustain Pulmonary Fibrosis in Mice, Study Finds

A rare form of immune T-cells promotes chronic inflammation and pulmonary fibrosis, researchers at the Johns Hopkins University School of Medicine found. Their discovery, made in a mice model of the disease, may lead to a new therapeutic target for lung fibrosis. The research report, “Deletion of mTORC1 activity in CD4+ T cells…